16 results
6-K
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:05am
situations, and product recall were conducted.
The Company conducted following actions to Cyber security.
◦The Information Security & Governance … to counter evolving cyber threats. Insurance coverage was obtained to reimburse certain costs related to significant cybersecurity events that Takeda
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
of advanced analytics and AI continues to accelerate, the TRUST team partnered with our Cyber Digital Trust team to issue guidance on the use of large
F-4
mzsbbasqgd cr
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
4nundps7 nvq7
27 Jun 19
Annual report (foreign)
6:41am
F-4/A
0fsyuhlq2kexxuw70
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
424B3
9gu8lvxsu178 tmbi7
14 Nov 19
Prospectus supplement
6:10am
6-K
EX-99.1
0mgxqjeq8cd76w
23 Jun 23
Current report (foreign)
6:13am
6-K
o6koci5i xks
30 May 19
Current report (foreign)
10:26am
6-K
EX-99.1
kjp82ez 2y3
30 May 23
Current report (foreign)
6:11am
DRS/A
3omy2fzil5f4gps7f56g
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
oz9xvj4lxjv0o8vk
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
i0o3kdw5hdbbr9r9
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
- Prev
- 1
- Next